共查询到20条相似文献,搜索用时 78 毫秒
1.
2.
由温州康宁医院精神卫生研究所副所长李方敏编著的《精神病患者劳动能力鉴定》一书和光盘电子版,日前由浙江西泠印社出版社出版并发行,全国各地新华书店均有销售。全书分25个章节,分别介绍了精神病患者劳动能力鉴定的有关概念、原则、程序、方法及精神病学有关概况,较详细地描述了精神病患者劳动能力鉴定中常见精神疾病的诊断、鉴定及案例,并对有争议的鉴定问题进行了讨论。该书既适用于从事鉴定工作的医务人员,又是各级劳动和社会保障部门、 相似文献
3.
4.
5.
6.
奥氮平致昏迷1例 总被引:1,自引:0,他引:1
陈建 《临床精神医学杂志》2009,19(4)
1病例
患者男性,73岁,36年前诊断为偏执型精神分裂症,既往有陈旧性心肌梗死,2型糖尿病,脑梗死.体格检查无明显异常,心电图显示窦性心律,异常Q波,各项化验大致正常,既往服用奋乃静、利培酮治疗,精神症状控制欠佳,换用奥氮平(商品名:悉敏),10 mg,2次/d,服用1年症状有所好转. 相似文献
7.
8.
1病例患者男,47岁,未婚,高中文化。烦躁,行为紊乱28年,头痛,眠差3d,入院诊断:脑外伤致精神障碍。经氯氮平150mg/d、丙戊酸钠0.8g/d合用1个月后症状改善,但仍存少许幻听,平时能与病友集体活动。随后逐步停用氯氮平,换用 相似文献
9.
<正>1病例患者女,43岁,北京籍,高中文化,无业,患者1994年5月1日(24岁时)工作被辞退后突然精神失常,表现哭笑无常,话多,乱语,自称是女皇,说其男友是皇帝,言语行为紊乱,被送入我院住院8个月,诊断精神分裂症,予奋乃静治疗(最高60 mg/d),显著好转出院,2003年3月21日,病情反复再次住院3个月,仍服用奋乃静最高量54 mg/d,好转出院,出院后一直奋乃静维持治疗,近5年奋乃静24 mg/d,病 相似文献
10.
胡建华 《临床精神医学杂志》2013,(6):432-432
1病例患者男,59岁,未婚,农民。因疑人害己,行为异常,夜眠差2个月余而入院。既往史、个人史、家族史均无特殊。体格检查未发现异常。精神检查:意识清,情感不协调,有被害妄想、关系妄想,无自知力。诊断:精神分裂症。 相似文献
11.
12.
13.
Denis M. O. Cheong Carlos A. Vaccaro Steven D. Waxner Virgilio D. Salanga Reginald C. Phillips Maurice R. Hanson 《Muscle & nerve》1995,18(6):612-619
The aim of this study was to assess the utility of electrodiagnostic testing (EDT) for the evaluation of fecal incontinence (FI). Over a 5-year period, 225 patients (174 females) with FI were prospectively studied with anal manometry, anal ultrasonography, anal electromyography (AEMG), and pudendal nerve terminal motor latency (PNTML) assessment. The mean age was 60 (range 12–94) years. Causes of FI identified by clinical evaluation were obstetric injuries (45), rectal prolapse (43), iatrogenic or other trauma (42), neurologic disease (23), and idiopathic (72). EDT revealed abnormalities in 76% of patients. The incidence of pudendal neuropathy (PN) was 36% (bilateral 21%, unilateral 15%). Patients with PN were older than were those with normal PNTML (mean 71 vs. 63 years; P < 0.002). No relationship between squeeze pressure and PN could be demonstrated (P = 0.9). Reduced motor unit potential (MUP) recruitment on AEMG was present in 60% and was associated with decreased squeeze pressure (P < 0.001) and increased MUP polyphasia (P < 0.001). Concurrence of AEMG and anal ultrasonographic findings was observed in 35 of 41 patients (84%). Defects were overlooked in one study but identified by the other on three occasions, each. Moreover, 8 of 22 patients with demonstrated sphincter defects had unsuspected PN or extensive sphincter injury on AEMG that precluded sphincter repair. In conclusion, EDT proved to be a valuable tool in the evaluation and subsequent treatment of patients with FI. © 1995 John Wiley & Sons, Inc. 相似文献
14.
OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a rare syndrome with four main symptoms: rigidity, hyperthermia, altered mental status and autonomic instability. We report a patient with an atypical manifestation of NMS. METHOD: A single case was reported. RESULTS: A patient with pneumonia developed delirium and was treated with olanzapine and developed a NMS with fluctuating hyperthermia and autonomic instability during a month. Only slight rigidity was present. Creatine kinase was not elevated. The patient was severely agitated and manic. After discontinuation of olanzapine the patient showed no psychopathology or hyperthermia. CONCLUSION: NMS should be considered when patients treated with antipsychotics develop one or more symptoms of NMS. 相似文献
15.
16.
17.
奥氮平治疗精神分裂症患者血液流变学变异分析 总被引:1,自引:0,他引:1
目的:调查住院期间精神分裂症患者使用奥氮平治疗前后血液流变学的指标变化情况.方法:分别于治疗前,使用奥氮平治疗4、8及12周对80例住院的精神分裂症患者的血液流变学进行测定.检测指标包括:全血比低切粘度、全血比高切粘度、血浆粘度、红细胞压积,并对上述指标进行比较分析.结果:全血比低切粘度、全血比高切粘度、血浆粘度在治疗第4、8及12周与治疗前相比,均呈下降趋势,尤其是在治疗第8、12周显著下降(P<0.01),而红细胞压积的变化无显著性(P>0.05).结论:血液流变学指标检测可作为精神分裂症的辅助检验项目,也可用作评价其疗效的参考指标. 相似文献
18.
19.
A 31-year old man, suffering from schizophrenia for 5 years was admitted to the psychiatric ward because of another exacerbation of schizophrenia. Olanzapine treatment was started, in dose 10 mg a day. During treatment mania was observed. First symptoms of hypomania appeared on the 5th day of treatment. Manic symptoms increased, the greatest escalation of mania was observed on the 13th day. Olanzapine dose was reduced to 5 mg a day, and haloperidol was added. Mania retreated. Finally the patient has been treated by haloperidol decanoate 100 mg every two weeks and olanzapine 5 mg a day. The illness has entered a period of remission. 相似文献